HCID 67095830, compound → HCID 57780695, compound

HRID 2076115Notes

Reaction equation

HRID 2076115 reaction equation
CN(C)[CH:3]=[C:4]1[CH2:9][CH2:8][CH2:7][CH:6]([C:10]([N:12]2[CH2:17][CH2:16][O:15][CH2:14][CH2:13]2)=[O:11])[C:5]1=O.[N+]([O-])(O)=O.[N+]([O-])(O)=O.[CH3:28][O:29][C:30]1[CH:31]=[C:32]([NH:42][C:43]([NH2:45])=[NH:44])[CH:33]=[CH:34][C:35]=1[N:36]1[CH:40]=[C:39]([CH3:41])[N:38]=[CH:37]1>>[CH3:28][O:29][C:30]1[CH:31]=[C:32]([NH:42][C:43]2[N:45]=[CH:3][C:4]3[CH2:9][CH2:8][CH2:7][CH:6]([C:10]([N:12]4[CH2:13][CH2:14][O:15][CH2:16][CH2:17]4)=[O:11])[C:5]=3[N:44]=2)[CH:33]=[CH:34][C:35]=1[N:36]1[CH:40]=[C:39]([CH3:41])[N:38]=[CH:37]1

Participants

3

Reactant 2

HCID 67095830HCID 67095830, compoundHCID 178493228HCID 178493228, compound

Product 1

HCID 57780695HCID 57780695, compound

Procedure

The title compound was prepared from 2-[1-dimethylamino-methylidene]-6-(morpholine-4-carbonyl)-cyclohexanone (16 mg, 0.06 mmol) and N-[3-methoxy-4-(4-methyl-imidazol-1-yl)-phenyl]-guanidine dinitrate (17 mg, 0.045 mmol) using in analogous manner the procedure described in example 45b). Obtained as a yellow solid (5 mg, 25%). MS ISP (m/e): 449.4 (100) [(M+H)+].

Sources & evidence

ORD record
ord-d0b74fe23c0d474aa3095b2fb49d800f
Source dataset
uspto-grants-2011_04
Patent number
US07923450B2

Reaction notes

Loading…